Moleculin Biotech Inc (NASDAQ: MBRX) is -85.64% lower on its value in year-to-date trading and has touched a low of $0.25 and a high of $4.71 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The MBRX stock was last observed hovering at around $0.39 in the last trading session, with the day’s gains setting it 0.13%.
Currently trading at $0.52, the stock is 12.57% and -30.89% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 92.01 million and changing 34.10% at the moment leaves the stock -66.53% off its SMA200. MBRX registered -69.33% loss for a year compared to 6-month loss of -70.54%. The firm has a 50-day simple moving average (SMA 50) of $0.75452 and a 200-day simple moving average (SMA200) of $1.55806.
The stock witnessed a -24.45% gain in the last 1 month and extending the period to 3 months gives it a -36.42%, and is 72.71% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 23.67% over the week and 15.92% over the month.
Moleculin Biotech Inc (MBRX) has around 17 employees, a market worth around $12.57M and $0.00M in sales. Distance from 52-week low is 108.56% and -88.92% from its 52-week high. The company has generated returns on investments over the last 12 months (-6312.23%).
The EPS is expected to grow by 75.21% this year.
Moleculin Biotech Inc (MBRX) Top Institutional Holders
24.0 institutions hold shares in Moleculin Biotech Inc (MBRX), with institutional investors hold 6.42% of the company’s shares. The shares outstanding are 24.10M, and float is at 21.99M with Short Float at 8.79%. Institutions hold 6.13% of the Float.
The top institutional shareholder in the company is ARMISTICE CAPITAL, LLC with over 0.16 million shares valued at $0.55 million. The investor’s holdings represent 6.1339% of the MBRX Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 84418.0 shares valued at $0.3 million to account for 3.3193 of the shares outstanding. The other top investors are LPL FINANCIAL LLC which holds 33754.0 shares representing 1.3272% and valued at over $0.12 million, while GEODE CAPITAL MANAGEMENT, LLC holds 0.7768 of the shares totaling 19756.0 with a market value of $68966.0.
Moleculin Biotech Inc (MBRX) Insider Activity
The most recent transaction is an insider purchase by Foster Jonathan P.,the company’sChief Financial Officer. SEC filings show that Foster Jonathan P. bought 270,270 shares of the company’s common stock on Jun 23 ’25 at a price of $0.37 per share for a total of $100000.0. Following the purchase, the insider now owns 0.29 million shares.
Moleculin Biotech Inc disclosed in a document filed with the SEC on Jun 23 ’25 that KLEMP WALTER V (CEO and President) bought a total of 675,675 shares of the company’s common stock. The trade occurred on Jun 23 ’25 and was made at $0.37 per share for $0.25 million. Following the transaction, the insider now directly holds 0.74 million shares of the MBRX stock.
